References:
Ackelsberg, J., Liddicoat, A., Burke, T., Szymczak, W. A., Levi, M. H.,
Ostrowsky, B., . . . Layton, M. (2020). Brucella Exposure Risk Events in
10 Clinical Laboratories, New York City, USA, 2015 to 2017. J.
Clin. Microbiol., 58 (2). doi:10.1128/jcm.01096-19
Al Dahouk, S., & Nöckler, K. (2011). Implications of laboratory
diagnosis on brucellosis therapy. Expert Rev Anti Infect Ther,
9 (7), 833-845. doi:10.1586/eri.11.55
Arapovic, J., Špičić, S., Duvnjak, S., Ostojić, M., Arapović, M.,
Nikolić, J., & Cvetnić, Ž. (2020). The first report of Brucella
melitensis Rev.1 human brucellosis in Bosnia and Herzegovina. J
Infect Dev Ctries, 14 (2), 232-235. doi:10.3855/jidc.11949
Ashford, D. A., di Pietra, J., Lingappa, J., Woods, C., Noll, H.,
Neville, B., . . . Perkins, B. A. (2004). Adverse events in humans
associated with accidental exposure to the livestock brucellosis vaccine
RB51. Vaccine, 22 (25-26), 3435-3439.
doi:10.1016/j.vaccine.2004.02.041
Blaney, D., Bosserman, E., Bui, D., Guerra, M., & Stoddard, R. (2009).Brucella Laboratory Exposures in the United States, 2008. Paper
presented at the Infectious Diseases Society of America Meeting.
Bosseray, N., & Plommet, M. (1990). Brucella suis S2, brucella
melitensis Rev. 1 and Brucella abortus S19 living vaccines: residual
virulence and immunity induced against three Brucella species challenge
strains in mice. Vaccine, 8 (5), 462-468.
doi:10.1016/0264-410x(90)90247-j
Bossi, P., Tegnell, A., Baka, A., van Loock, F., Hendriks, J., Werner,
A., . . . Gouvras, G. (2004). Bichat guidelines for the clinical
management of brucellosis and bioterrorism-related brucellosis.Euro Surveill., 9 (12), 33-34. doi:10.2807/esm.09.12.00506-en
Bouza, E., Sánchez-Carrillo, C., Hernangómez, S., & González, M. J.
(2005). Laboratory-acquired brucellosis: a Spanish national survey.J. Hosp. Infect., 61 (1), 80-83. doi:10.1016/j.jhin.2005.02.018
Cossaboom, C. M., Kharod, G. A., Salzer, J. S., Tiller, R. V., Campbell,
L. P., Wu, K., . . . Stonecipher, S. (2018). Notes from the Field:
Brucella abortus Vaccine Strain RB51 Infection and Exposures Associated
with Raw Milk Consumption - Wise County, Texas, 2017. MMWR Morb.
Mortal. Wkly. Rep., 67 (9), 286. doi:10.15585/mmwr.mm6709a4
Dean, A., Schelling, E., & Zinsstag, J. (2014). Brucellosis.Neglected Tropical Diseases .
Deng, Y., Liu, X., Duan, K., & Peng, Q. (2019). Research Progress on
Brucellosis. Curr. Med. Chem., 26 (30), 5598-5608.
doi:10.2174/0929867325666180510125009
Eschenbrenner, M., Wagner, M. A., Horn, T. A., Kraycer, J. A., Mujer, C.
V., Hagius, S., . . . DelVecchio, V. G. (2002). Comparative proteome
analysis of Brucella melitensis vaccine strain Rev 1 and a virulent
strain, 16M. J. Bacteriol., 184 (18), 4962-4970.
doi:10.1128/jb.184.18.4962-4970.2002
Fiori, P. L., Mastrandrea, S., Rappelli, P., & Cappuccinelli, P.
(2000). Brucella abortus infection acquired in microbiology
laboratories. J. Clin. Microbiol., 38 (5), 2005-2006.
Hatcher, S. M., Shih, D., Holderman, J., Cossaboom, C., Leman, R., &
DeBess, E. (2018). Notes from the Field: Adverse Event Associated with
Unintentional Exposure to the Brucella abortus RB51 Vaccine - Oregon,
December 2017. MMWR Morb. Mortal. Wkly. Rep., 67 (26), 747.
doi:10.15585/mmwr.mm6726a4
Jiang, H., Dong, H., Peng, X., Feng, Y., Zhu, L., Niu, K., . . . Ding,
J. (2018). Transcriptome analysis of gene expression profiling of
infected macrophages between Brucella suis 1330 and live attenuated
vaccine strain S2 displays mechanistic implication for regulation of
virulence. Microb. Pathog., 119 , 241-247.
doi:10.1016/j.micpath.2018.04.003
Jiang, W., Chen, J., Li, Q., Jiang, L., Huang, Y., Lan, Y., & Li, Y.
(2019). Epidemiological characteristics, clinical manifestations and
laboratory findings in 850 patients with brucellosis in Heilongjiang
Province, China. BMC Infect. Dis., 19 (1), 439.
doi:10.1186/s12879-019-4081-5
Kairu-Wanyoike, S., Nyamwaya, D., Wainaina, M., Lindahl, J., Ontiri, E.,
Bukachi, S., . . . Bett, B. (2019). Positive association between
Brucella spp. seroprevalences in livestock and humans from a
cross-sectional study in Garissa and Tana River Counties, Kenya.PLoS Negl Trop Dis, 13 (10), e0007506.
doi:10.1371/journal.pntd.0007506
Laboratory-acquired brucellosis–Indiana and Minnesota, 2006. (2008).MMWR Morb. Mortal. Wkly. Rep., 57 (2), 39-42.
Lowe, C. F., Showler, A. J., Perera, S., McIntyre, S., Qureshi, R.,
Patel, S. N., . . . Muller, M. P. (2015). Hospital-associated
transmission of Brucella melitensis outside the laboratory.Emerging Infect. Dis., 21 (1), 150-152. doi:10.3201/eid2101.141247
Memish, Z. A., & Mah, M. W. (2001). Brucellosis in laboratory workers
at a Saudi Arabian hospital. Am J Infect Control, 29 (1), 48-52.
doi:10.1067/mic.2001.111374
Osman, A. E., Hassan, A. N., Ali, A. E., Abdoel, T. H., & Smits, H. L.
(2015). Brucella melitensis Biovar 1 and Brucella abortus S19 Vaccine
Strain Infections in Milkers Working at Cattle Farms in the Khartoum
Area, Sudan. PLoS ONE, 10 (5), e0123374.
doi:10.1371/journal.pone.0123374
Pappas, G. (2010). The changing Brucella ecology: novel reservoirs, new
threats. Int. J. Antimicrob. Agents, 36 Suppl 1 , S8-11.
doi:10.1016/j.ijantimicag.2010.06.013
Pien, B. C., Saah, J. R., Miller, S. E., & Woods, C. W. (2006). Use of
sentinel laboratories by clinicians to evaluate potential bioterrorism
and emerging infections. Clin. Infect. Dis., 42 (9), 1311-1324.
doi:10.1086/503260
Pike, R. M. L. (1976). Laboratory associated infections: summary and
analysis of 3921 cases. Health Lab Sci, 13 (2), 105-114.
Robichaud, S., Libman, M., Behr, M., & Rubin, E. (2004). Prevention of
laboratory-acquired brucellosis. Clin. Infect. Dis., 38 (12),
e119-122. doi:10.1086/421024
Saddique, A., Ali, S., Akhter, S., Khan, I., Neubauer, H., Melzer, F., .
. . El-Adawy, H. (2019). Acute Febrile Illness Caused by Brucella
abortus Infection in Humans in Pakistan. Int J Environ Res Public
Health, 16 (21). doi:10.3390/ijerph16214071
Sayin-Kutlu, S., Kutlu, M., Ergonul, O., Akalin, S., Guven, T.,
Demiroglu, Y. Z., . . . Akova, M. (2012). Laboratory-acquired
brucellosis in Turkey. J. Hosp. Infect., 80 (4), 326-330.
doi:10.1016/j.jhin.2011.12.020
Sewell, D. L. (1995). Laboratory-Associated Infections and Biosafety.Clinical Microbiology Reviews, 8 (3), 389-405.
Sewell, D. L. (2006). Laboratory-acquired infections: Are
microbiologists at risk? Clin. Microbiol. Newsl., 28 (1), 1-6.
doi:10.1016/j.clinmicnews.2005.12.004
Shang, D., Xiao, D., & Yin, J. (2002). Epidemiology and control of
brucellosis in China. Veterinary Microbiology, 90 (1-4), 165-182.
Stephanie, N., Richard, G., Molly, K., Limberger, R. J., Karen, D. A.,
Louise, C., . . . Nellie, D. (2004). Laboratory-acquired Brucellosis.Emerging Infectious Diseases, 10 (10), 1848-1850.
Venyo, A. K. G. (2015). Brucellosis of testis and epididymis: a review
of the literature. British Journal of Medicine & Medical
Research .
Yagupsky, P., & Baron, E. J. (2005). Laboratory exposures to brucellae
and implications for bioterrorism. Emerging Infect. Dis., 11 (8),
1180-1185. doi:10.3201/eid1108.041197
Yang, H., Zhang, S., Wang, T., Zhao, C., Zhang, X., Hu, J., . . . Zhen,
Q. (2020). Epidemiological Characteristics and Spatiotemporal Trend
Analysis of Human Brucellosis in China, 1950-2018. Int J Environ
Res Public Health, 17 (7). doi:10.3390/ijerph17072382
Zhang P, F. C., Cui BY. (2018). A report of a brucellosis outbreak
caused by vaccination. Disease Surveillance, 33(3) , 222-224.
doi:10.3784/j.issn.1003-9961.2018.03.013
Zhu, L., Feng, Y., Zhang, G., Jiang, H., Zhang, Z., Wang, N., . . . Suo,
X. (2016). Brucella suis strain 2 vaccine is safe and protective against
heterologous Brucella spp. infections. Vaccine, 34 (3), 395-400.
doi:10.1016/j.vaccine.2015.09.116
Table 1. Epidemiology and clinical diagnosis characteristics of patients
with brucellosis